Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NEUROON-MED

Financiado

Cerrado

NEUROON MED the future of at home diagnosis of sleep disorders

More than 100 million people suffer from sleep apnea (SA) worldwide according to the WHO data. People with SA have a life expectancy 20 years shorter than the average life span. Additionally, they have a three- to sevenfold increa... ver más

31/05/2020

INTELICLINIC SP. Z...

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

INTELICLINIC SP. Z.O.O. No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-05-31

SMEInst-01-2016-2017: Open Disruptive Innovation Scheme

I+D

Cerrada hace 8 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

INTELICLINIC SP. Z.O.O.

1.62M€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

Sleepwise Non intrusive solution for Obstructive Sleep Apnea Syndrome 71K€ Cerrado

Sensa Effortlessly Diagnosing Sleep Apnea with the Sensa Platform 71K€ Cerrado

Sleep for All Diagnostics of sleep disorders for all patient groups 3M€ Cerrado

DPI2017-84280-R SIMPLIFICACION DEL DIAGNOSTICO DE LA APNEA DEL SUEÑO INFANTI... 188K€ Cerrado

TIN2013-40686-P ANALISIS INTELIGENTE DE SEÑALES NEUROLOGICAS Y CONSTRUCCION... 21K€ Cerrado

S-trodes Reliable Medical Grade Home-Based Test for Self-Use for peop... 4M€ Cerrado

Duración del proyecto: 36 meses Fecha Inicio: 2017-05-31
Fecha Fin: 2020-05-31

Líder del proyecto

INTELICLINIC SP. Z.O.O. No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto More than 100 million people suffer from sleep apnea (SA) worldwide according to the WHO data. People with SA have a life expectancy 20 years shorter than the average life span. Additionally, they have a three- to sevenfold increased risk of motor vehicle crashes. The economic impact of sleep disorders is massive, specialists from the Harvard School of medicine calculated that costs of SA only in the US accounts for $115 billion every year. The main problem the world is facing with stopping the SA epidemic is not a treatment but diagnosis. It is estimated that 85% of people who suffer from SA have never been diagnosed. The reason for the low screening rate of SA is a limited access to polysomnography (PSG) – the gold standard for testing sleep disorders. At Inteliclinic, we have developed the NeuroOn-MED mask which is addressing the customers need for effective and inexpensive solution for home diagnosis of SA. Our advantage over competitors is built upon the technological excellence of NeuroOn-MED, which analyses the brainwaves and eye movements in the same way as PSG does. The sensors of NeuroOn-MED (EEG, EOG, pulse oximetry, and others) combined with artificial intelligence algorithms for sleep data analysis provide +90% of PSG effectiveness, allowing for distinguishing between sleep stages and various variants of SA. Comparing with the currently offered home sleep monitors which are capable only of diagnosing moderate and severe SA cases. Moreover, the price of our device will be lower than currently offered solutions. NeuroOn-MED is perfectly aligned with new trends in remote diagnosis of sleep disorders. The market of SA diagnostic devices is expected to reach a value of $7.3 billion in 2018, with a CAGR of 15.0%. The proposed SMEI-funded project will be focused on clinical studies of the NeuroOn-MED, which will lead to registration as a medical device and fast commercialisation on European and US markets in 2019-20.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores